Clin Ultrasound.  2024 May;9(1):1-17. 10.18525/cu.2024.9.1.1.

Assessment of Hepatic Steatosis Using Ultrasound-Based Techniques: Focus on Fat Quantification

• Rou WS

• KMID: 2556121
• DOI: http://doi.org/10.18525/cu.2024.9.1.1

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, affecting more than 30% of the global population, and is associated with increased liver-related morbidity and mortality, and extrahepatic complications. With the increasing prevalence of MASLD, there is an urgent need for accessible, non-invasive methods to detect hepatic steatosis. Currently, liver biopsy and magnetic resonance imaging proton density fat fraction are considered reference standards for diagnosing hepatic steatosis; however, their invasiveness and limited accessibility limit their widespread use. Ultrasonography (US) is a promising alternative owing to its cost-effectiveness and widespread accessibility. Recently, quantitative US techniques have been developed and commercialized by several vendors to measure steatosis by detecting changes in various acoustic properties associated with hepatic steatosis, making it readily accessible. Controlled attenuation parameter (CAP), which evaluates hepatic steatosis using the attenuation of the US beam, is the most widely studied algorithm as a non-imaging technique. Several other algorithms are also available on B-mode ultrasound systems, and their diagnostic performance is comparable to or better than that of the CAP. Therefore, we aimed to review current US-based methods for detecting and grading hepatic steatosis, discussing their diagnostic performance and utilization.

Keyword

Ultrasound; Steatosis; Fatty liver; Quantification; Attenuation